FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022

Jul 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-07-18

Reporting Person: RALLIS CHRIS A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-18	Common Shares	M	11111	$0.45	Acquired	32036	Direct
2022-07-18	Common Shares	F	4379	$6.70	Disposed	27657	Direct

Footnotes

F1: Represents options granted on August 17, 2012, with a $0.45 USD strike price and an expiration of August 17, 2022.

F2: Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 11,111 shares from an August 17, 2012 grant.